查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球原位雜交市場:按產品類型,技術,探針類型,應用,最終用戶,地區,機會,預測2017-2031 年
市場調查報告書
商品編碼
1422065

全球原位雜交市場:按產品類型,技術,探針類型,應用,最終用戶,地區,機會,預測2017-2031 年

In situ Hybridization Market Assessment, By Product Type, By Technology, By Probe Type, By Application, By End-Users, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 224 Pages | 商品交期: 3-5個工作天內

價格

2023年全球原位雜交市場規模達16.4億美元。預計到 2031 年，市場規模將達到 35.3 億美元，2024-2031 年預測期間複合年增長率為 10.04%。全球原位雜交市場充滿活力，前景廣闊，擁有強大的產品和有利的市場策略。原位雜交市場的推動因素包括癌症患者和遺傳疾病盛行率的增加、原位雜交技術在研發中的使用案例的增加以及分子生物學和基因組學的進步。

原位雜交技術在癌症等疾病的診斷和治療中的有效性已得到證實，並已被醫療保健專業人員廣泛採用。近年來，一些研究機構進行了廣泛的研究，以探索原位雜交的潛力。它加強了研發場景，並導致對此類產品的需求顯著成長。因此，全球癌症患者數量的增加是推動需求的主要因素，因為原位雜交技術在檢測癌細胞和基因突變方面非常有效。我是。然而，產品成本高、缺乏熟練的專業人員以及複雜的數據解釋是阻礙全球原位雜交市場成長的因素。

該報告研究了全球原位雜交市場，並按產品類型、技術、探針類型、應用、最終用戶、地區以及參與市場的公司概況提供了市場概述。更多的。

目錄

第一章研究方法論

第二章 專案範圍與定義

第三章執行摘要

第四章2017-2031年全球原位雜交市場展望

  • 市場規模及預測
  • 按產品類型
  • 按技術
  • 按探頭類型
  • 按用途
  • 按最終用戶
  • 按地區
  • 按公司劃分的市佔率 (%)，2023 年

第五章2017-2031年全球原位雜交市場展望

  • 北美
  • 歐洲
  • 南美洲
  • 亞太地區
  • 中東/非洲

第 6 章 市場測繪，2023 年

第七章 宏觀環境與產業結構

  • 供需分析
  • 進出口分析 - 數量和價值
  • 供應/價值鏈分析
  • PESTEL 分析
  • 波特五力分析

第八章市場動態

第九章 監理架構與創新

第十章 主要與企業狀況

第11章價格分析

第十二章案例研究

第十三章 主要公司展望

  • Illumina, Inc.
  • Thermo Fisher Scientific Inc.
  • Bio-Techne Corporation
  • Agilent Technologies Inc.
  • Qiagen NV
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • PerkinElmer Inc.
  • Myriad Genetics Inc.
  • Leica Biosystems Nussloch GmbH
  • Genemed Biotechnologies, Inc.
/p>

第十四章 戰略建議

第十五章 查詢及免責聲明

Product Code: MX10930

Global in situ hybridization market size was valued at USD 1.64 billion in 2023 and is expected to reach USD 3.53 billion in 2031, with a CAGR of 10.04% for the forecast period between 2024 and 2031F. The global in situ hybridization market is highly dynamic and promising, with a robust product and favorable market tactics. The in-situ hybridization market is expected to be driven by factors such as the increasing prevalence of cancer cases and genetic disorders, the growing use of in-situ hybridization techniques in research and development, and advancements in molecular biology and genomics.

The proven efficacy of in situ hybridization techniques in diagnosing and managing diseases like cancer led to their growing adoption by healthcare professionals. Several research organizations have spent the last few years conducting extensive research to explore possibilities around in situ hybridization. It has enhanced the research and development scenario and led to significant growth in demand for such products. Hence, growing cancer cases across the globe is a major factor driving the demand for in situ hybridization techniques as it is highly efficient in detecting cancerous cells and genetic mutations. However, the high cost associated with products, lack of highly skilled professionals, and interpretation of complicated data are some hindrances in the growth of the global in situ hybridization market.

In May 2023, Bio-Techne announced the expansion of the Advanced Cell Diagnostics (ACD)-branded RNAscope in situ hybridization (ISH) portfolio with the commercialization of RNAscope multi-omic workflow for the Standard BioTools Hyperion Imaging System.

Bio-Techne is an international life sciences firm providing innovative tools and bioactive reagents for research and clinical diagnostics. The RNAscope is considered the gold standard for in situ hybridization and is trusted by biotechnological researchers worldwide, with a rapidly growing list of over 8,000 peer-reviewed publications.

Increasing Prevalence of Cancer Cases and Genetic Disorders

In situ hybridization techniques are used in genetic testing for cancers. These techniques help to detect chromosomal changes in patients and help healthcare professionals to identify the type of cancer, based on which the treatment is designed. Due to vast applications of in situ hybridization, techniques in the diagnosis of cancers and other genetic diseases are further driving the demand in the market. Besides cancers, in situ hybridization techniques are extensively utilized to diagnose other indications like infectious, viral, and immunological diseases. The American Society of Cancer estimates that 1,958,310 new cancer cases and 609,820 cancer deaths in the United States. Cancer Research UK estimates that there will be 28 million cancer cases per year by 2040. It states that the United Kingdom's incidence is ranked higher than 90% of the world.

Growing Research and Development

The global in situ hybridization market is positively impacted by increased research and development surrounding genome exploration, diagnostic research, and its other healthcare and life sciences applications. Over the past few decades, the human genome project has significantly contributed to the growing body of research concerning genetic explorations and life sciences research. The market is anticipated to rise significantly with the growing acceptance and application of in situ hybridization in diagnostic centers, hospitals, and institutional and academic research projects. To increase their worldwide presence, major companies in the market are pursuing tactics including new launches, mergers and acquisitions, and partnerships.

In February 2023, Molecular Instruments (MI), which is a biotech firm under the umbrella of the California Institute of Technology, launched HCR RNA-CISH. The product is expected to stimulate automated chromogenic in situ hybridization (ISH) workflows that depend on Bio-Techne's RNAscope. According to the company, HCR RNA-CISH kits offer twice the turnaround time and half the cost of any current chromogenic in situ hybridization (CISH) method, while delivering superior performance. HCR RNA-CISH has native support for IHC codetection and is fully compatible with all popular automation platforms.

Fluorescent in Situ Hybridization (FISH) is Expected to Dominate During Forecast Period

The fluorescent in situ hybridization (FISH) technique finds a vast range of usage in the diagnosis of congenital disorders like Down's syndrome and other genetic diseases including cancer detection and identification. The growing application areas of fluorescent in situ hybridization (FISH) and its growing demand due to the rising burden of cancers and other genetic diseases is expected to make the fluorescent in situ hybridization (FISH) segment dominate the in situ hybridization market. The COVID-19 pandemic significantly boosted in situ hybridization and several research was done on it. For instance, in September 2023, a group of researchers published a protocol in STAR protocol, for the detection of infectious SARS-CoV-2 virus at low levels through in situ hybridization techniques.

North America to Lead the Global In situ Hybridization Market

North America is anticipated to dominate the market with the highest value share regarding its significant investment in research and development, technical breakthroughs made by major companies, highly developed healthcare infrastructure, and well-established research environment in North American nations like the United States and Canada. The government's actions and initiatives to assist medication development, genetic exploration, and cancer treatment contribute to the market's growth.

Key Players Landscape and Outlook

Market players are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products using a variety of tactics. Companies are expanding the range of products they offer to gain market share. Industry participants are using a variety of growth methods, including collaborations, mergers and acquisitions, partnerships, product launches, and development of new solutions, to bolster their position in the market.

In October 2023, Ikonisys SA partnered with Biocare Medical to expand the FISH diagnostic product portfolio. Biocare Medical is a leading firm providing immunohistochemistry (IHC) and Fluorescent in situ hybridization (FISH) tools and reagents while Ikonisys SA specializes in early and accurate detection of cancer through its unique fully automated solution for medical diagnostic labs. This partnership focuses on expanding the global distribution of products of Ikonisys SA, especially, the low-volume Ikoniscope20 and high-volume Ikoniscope20max. Earlier, Biocare Medical acquired Empire Genomics to expand its offering to include over 1 million FISH probes.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global In Situ Hybridization Market Outlook, 2017-2031F

  • 4.1. Market Size & Forecast
    • 4.1.1. By Value
    • 4.1.2. By Volume
  • 4.2. By Product Type
    • 4.2.1. Consumables
    • 4.2.2. Instruments
    • 4.2.3. Software
  • 4.3. By Technology
    • 4.3.1. Fluorescent in situ hybridization (FISH)
    • 4.3.2. Chromogenic in situ hybridization (CISH)
  • 4.4. By Probe Type
    • 4.4.1. DNA
    • 4.4.2. RNA
  • 4.5. By Application
    • 4.5.1. Oncology
    • 4.5.2. Neurology
    • 4.5.3. Cytology
    • 4.5.4. Immunology
    • 4.5.5. Infectious Diseases
    • 4.5.6. Developmental Biology
    • 4.5.7. Others
  • 4.6. By End-Users
    • 4.6.1. Hospitals and Diagnostic Organizations
    • 4.6.2. Clinical Research Organizations
    • 4.6.3. Academics and Research Institutions
    • 4.6.4. Pharmaceutical and Biotechnology Companies
    • 4.6.5. Others
  • 4.7. By Region
    • 4.7.1. North America
    • 4.7.2. Europe
    • 4.7.3. Asia Pacific
    • 4.7.4. South America
    • 4.7.5. Middle East & Africa
  • 4.8. By Company Market Share (%), 2023

5. Global In situ Hybridization Market Outlook, 2017-2031F

  • 5.1. North America
    • 5.1.1. Market Size & Forecast
      • 5.1.1.1. By Value
      • 5.1.1.2. By Volume
    • 5.1.2. By Product Type
      • 5.1.2.1. Consumables
      • 5.1.2.2. Instruments
      • 5.1.2.3. Software
    • 5.1.3. By Technology
      • 5.1.3.1. Fluorescent in situ hybridization (FISH)
      • 5.1.3.2. Chromogenic in situ hybridization (CISH)
    • 5.1.4. By Probe Type
      • 5.1.4.1. DNA
      • 5.1.4.2. RNA
    • 5.1.5. By Application
      • 5.1.5.1. Oncology
      • 5.1.5.2. Neurology
      • 5.1.5.3. Cytology
      • 5.1.5.4. Immunology
      • 5.1.5.5. Infectious Diseases
      • 5.1.5.6. Developmental Biology
      • 5.1.5.7. Others
    • 5.1.6. By End-Users
      • 5.1.6.1. Hospitals and Diagnostic Organizations
      • 5.1.6.2. Clinical Research Organizations
      • 5.1.6.3. Academics and Research Institutions
      • 5.1.6.4. Pharmaceutical and Biotechnology Companies
      • 5.1.6.5. Others
    • 5.1.7. United States*
      • 5.1.7.1. Market Size & Forecast
      • 5.1.7.1.1. By Value
      • 5.1.7.1.2. By Volume
      • 5.1.7.2. By Product Type
      • 5.1.7.2.1. Consumables
      • 5.1.7.2.2. Instruments
      • 5.1.7.2.3. Software
      • 5.1.7.3. By Technology
      • 5.1.7.3.1. Fluorescent in situ hybridization (FISH)
      • 5.1.7.3.2. Chromogenic in situ hybridization (CISH)
      • 5.1.7.4. By Probe Type
      • 5.1.7.4.1. DNA
      • 5.1.7.4.2. RNA
      • 5.1.7.5. By Application
      • 5.1.7.5.1. Oncology
      • 5.1.7.5.2. Neurology
      • 5.1.7.5.3. Cytology
      • 5.1.7.5.4. Immunology
      • 5.1.7.5.5. Infectious Diseases
      • 5.1.7.5.6. Developmental Biology
      • 5.1.7.5.7. Others
      • 5.1.7.6. By End-Users
      • 5.1.7.6.1. Hospitals and Diagnostic Organizations
      • 5.1.7.6.2. Clinical Research Organizations
      • 5.1.7.6.3. Academics and Research Institutions
      • 5.1.7.6.4. Pharmaceutical and Biotechnology Companies
      • 5.1.7.6.5. Others
    • 5.1.8. Canada
    • 5.1.9. Mexico

All segments will be provided for all regions and countries covered:

  • 5.2. Europe
    • 5.2.1. Germany
    • 5.2.2. France
    • 5.2.3. Italy
    • 5.2.4. United Kingdom
    • 5.2.5. Russia
    • 5.2.6. Netherlands
    • 5.2.7. Spain
    • 5.2.8. Turkey
    • 5.2.9. Poland
  • 5.3. South America
    • 5.3.1. Brazil
    • 5.3.2. Argentina
  • 5.4. Asia-Pacific
    • 5.4.1. India
    • 5.4.2. China
    • 5.4.3. Japan
    • 5.4.4. Australia
    • 5.4.5. Vietnam
    • 5.4.6. South Korea
    • 5.4.7. Indonesia
    • 5.4.8. Philippines
  • 5.5. Middle East & Africa
    • 5.5.1. Saudi Arabia
    • 5.5.2. UAE
    • 5.5.3. South Africa

6. Market Mapping, 2023

  • 6.1. By Type
  • 6.2. By Technology
  • 6.3. By Probe Type
  • 6.4. By Application
  • 6.5. By End-user
  • 6.6. By Region

7. Macro Environment and Industry Structure

  • 7.1. Supply Demand Analysis
  • 7.2. Import Export Analysis - Volume and Value
  • 7.3. Supply/Value Chain Analysis
  • 7.4. PESTEL Analysis
    • 7.4.1. Political Factors
    • 7.4.2. Economic System
    • 7.4.3. Social Implications
    • 7.4.4. Technological Advancements
    • 7.4.5. Environmental Impacts
    • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 7.5. Porter's Five Forces Analysis
    • 7.5.1. Supplier Power
    • 7.5.2. Buyer Power
    • 7.5.3. Substitution Threat
    • 7.5.4. Threat from New Entrant
    • 7.5.5. Competitive Rivalry

8. Market Dynamics

  • 8.1. Growth Drivers
  • 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

  • 9.1. Clinical Trial
  • 9.2. Patent Landscape
  • 9.3. Regulatory Approvals
  • 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

  • 10.1. Competition Matrix of Top Five Market Leaders
  • 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
  • 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 10.4. SWOT Analysis (For Five Market Players)
  • 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

  • 13.1. Illumina, Inc.,
    • 13.1.1. Company Details
    • 13.1.2. Key Management Personnel
    • 13.1.3. Products & Services
    • 13.1.4. Financials (As reported)
    • 13.1.5. Key Market Focus & Geographical Presence
    • 13.1.6. Recent Developments
  • 13.2. Thermo Fisher Scientific Inc.
  • 13.3. Bio-Techne Corporation
  • 13.4. Agilent Technologies Inc.
  • 13.5. Qiagen NV
  • 13.6. F. Hoffmann-La Roche Ltd
  • 13.7. Merck KGaA
  • 13.8. PerkinElmer Inc.
  • 13.9. Myriad Genetics Inc.
  • 13.10. Leica Biosystems Nussloch GmbH
  • 13.11. Genemed Biotechnologies, Inc.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 3. Global In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 4. Global In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 5. Global In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 6. Global In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 7. Global In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 8. Global In situ Hybridization Market Share (%), By Region, 2017-2031F
  • Figure 9. North America In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 10. North America In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 11. North America In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 12. North America In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 13. North America In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 14. North America In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 15. North America In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 16. North America In situ Hybridization Market Share (%), By Country, 2017-2031F
  • Figure 17. United States In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 18. United States In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 19. United States In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 20. United States In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 21. United States In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 22. United States In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 23. United States In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 24. Canada In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 25. Canada In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 26. Canada In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 27. Canada In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 28. Canada In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 29. Canada In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 30. Canada In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 31. Mexico In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 32. Mexico In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 33. Mexico In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 34. Mexico In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 35. Mexico In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 36. Mexico In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 37. Mexico In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 38. Europe In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 39. Europe In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 40. Europe In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 41. Europe In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 42. Europe In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 43. Europe In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 44. Europe In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 45. Europe In situ Hybridization Market Share (%), By Country, 2017-2031F
  • Figure 46. Germany In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 47. Germany In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 48. Germany In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 49. Germany In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 50. Germany In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 51. Germany In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 52. Germany In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 53. France In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 54. France In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 55. France In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 56. France In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 57. France In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 58. France In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 59. France In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 60. Italy In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Italy In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 62. Italy In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 63. Italy In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 64. Italy In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 65. Italy In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 66. Italy In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 67. United Kingdom In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 68. United Kingdom In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 69. United Kingdom In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 70. United Kingdom In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 71. United Kingdom In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 72. United Kingdom In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 73. United Kingdom In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 74. Russia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 75. Russia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 76. Russia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 77. Russia In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 78. Russia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 79. Russia In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 80. Russia In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 81. Netherlands In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 82. Netherlands In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 83. Netherlands In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 84. Netherlands In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 85. Netherlands In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 86. Netherlands In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 87. Netherlands In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 88. Spain In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 89. Spain In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 90. Spain In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 91. Spain In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 92. Spain In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 93. Spain In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 94. Spain In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 95. Turkey In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 96. Turkey In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 97. Turkey In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 98. Turkey In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 99. Turkey In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 100. Turkey In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 101. Turkey In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 102. Poland In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. Poland In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 104. Poland In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 105. Poland In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 106. Poland In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 107. Poland In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 108. Poland In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 109. South America In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 110. South America In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 111. South America In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 112. South America In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 113. South America In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 114. South America In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 115. South America In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 116. South America In situ Hybridization Market Share (%), By Country, 2017-2031F
  • Figure 117. Brazil In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 118. Brazil In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 119. Brazil In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 120. Brazil In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 121. Brazil In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 122. Brazil In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 123. Brazil In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 124. Argentina In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 125. Argentina In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 126. Argentina In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 127. Argentina In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 128. Argentina In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 129. Argentina In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 130. Argentina In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 131. Asia-Pacific In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 132. Asia-Pacific In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 133. Asia-Pacific In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 134. Asia-Pacific In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 135. Asia-Pacific In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 136. Asia-Pacific In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 137. Asia- Pacific In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 138. Asia-Pacific In situ Hybridization Market Share (%), By Country, 2017-2031F
  • Figure 139. India In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 140. India In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 141. India In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 142. India In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 143. India In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 144. India In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 145. India In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 146. China In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 147. China In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 148. China In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 149. China In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 150. China In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 151. China In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 152. China In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 153. Japan In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 154. Japan In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 155. Japan In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 156. Japan In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 157. Japan In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 158. Japan In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 159. Japan In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 160. Australia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 161. Australia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 162. Australia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 163. Australia In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 164. Australia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 165. Australia In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 166. Australia In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 167. Vietnam In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 168. Vietnam In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 169. Vietnam In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 170. Vietnam In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 171. Vietnam In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 172. Vietnam In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 173. Vietnam In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 174. South Korea In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 175. South Korea In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 176. South Korea In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 177. South Korea In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 178. South Korea In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 179. South Korea In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 180. South Korea In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 181. Indonesia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 182. Indonesia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 183. Indonesia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 184. Indonesia In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 185. Indonesia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 186. Indonesia In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 187. Indonesia In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 188. Philippines In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 189. Philippines In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 190. Philippines In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 191. Philippines In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 192. Philippines In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 193. Philippines In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 194. Philippines In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 195. Middle East & Africa In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 196. Middle East & Africa In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 197. Middle East & Africa In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 198. Middle East & Africa In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 199. Middle East & Africa In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 200. Middle East & Africa In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 201. Middle East & Africa In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 202. Middle East & Africa In situ Hybridization Market Share (%), By Country, 2017-2031F
  • Figure 203. Saudi Arabia In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 204. Saudi Arabia In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 205. Saudi Arabia In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 206. Saudi Arabia In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 207. Saudi Arabia In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 208. Saudi Arabia In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 209. Saudi Arabia In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 210. UAE In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 211. UAE In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 212. UAE In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 213. UAE In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 214. UAE In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 215. UAE In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 216. UAE In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 217. South Africa In situ Hybridization Market, By Value, In USD Billion, 2017-2031F
  • Figure 218. South Africa In situ Hybridization Market, By Volume, In Million Units, 2017-2031F
  • Figure 219. South Africa In situ Hybridization Market Share (%), By Product Type, 2017-2031F
  • Figure 220. South Africa In situ Hybridization Market Share (%), By Technology, 2017-2031F
  • Figure 221. South Africa In situ Hybridization Market Share (%), By Probe Type, 2017-2031F
  • Figure 222. South Africa In situ Hybridization Market Share (%), By Application, 2017-2031F
  • Figure 223. South Africa In situ Hybridization Market Share (%), By End-users, 2017-2031F
  • Figure 224. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 225. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 226. By Probe Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 227. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 228. By End-users Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 229. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023